Straits Times Index
3,439.88 +24.37 (+0.71%) S&P 500
5,537.02 +28.01 (+0.51%) Dow
39,308.00 -23.90 (-0.06%) Nasdaq
18,188.30 +159.54 (+0.88%) Bitcoin USD
57,890.44 -2,269.22 (-3.77%) CMC Crypto 200
1,211.30 -49.89 (-3.96%)
Aster DM Healthcare Limited (ASTERDM.BO)
| Previous close | 346.90 |
| Open | 347.00 |
| Bid | 345.00 x 0 |
| Ask | 345.15 x 0 |
| Day's range | 343.25 - 349.95 |
| 52-week range | 293.85 - 558.30 |
| Volume | |
| Avg. volume | 990,158 |
| Market cap | 171.74B |
| Beta (5Y monthly) | 0.67 |
| PE ratio (TTM) | 95.60 |
| EPS (TTM) | 3.61 |
| Earnings date | 12 Aug 2024 - 16 Aug 2024 |
| Forward dividend & yield | 4.00 (1.15%) |
| Ex-dividend date | 21 Aug 2024 |
| 1y target est | N/A |
- Reuters
PE firm Olympus to sell up to $235 million stake in India's Aster DM, term sheet shows
(Reuters) -Private equity firm Olympus Capital Asia plans to sell a 9.8% stake in India's Aster DM Healthcare for up to 19.53 billion rupees (nearly $235 million), according to a term sheet seen by Reuters on Tuesday. Olympus Capital, which owns about 19% stake in the hospital chain, is planning the sale at 400-437.20 rupees per share. The low end of the range represents an 8.5% discount to the Aster DM stock's last close and no discount at the upper range.
- Reuters
India's Aster DM posts first quarterly profit rise in five quarters
Aster DM Healthcare posted its first increase in quarterly profit since the first quarter of fiscal 2023 on the back of strong performance at the company's domestic hospitals segment. Consolidated net profit for the third quarter rose 28.6% to 1.79 billion rupees ($21.6 million), the company said on Thursday. While Aster's India business accounts for roughly a quarter of its revenue and Gulf Cooperation Council countries the rest, the company has focussed on expanding within India.
- Reuters
India's Aster mulls dividend payout from $1 billion Gulf demerger amid proxy firm pressure
India's Aster DM Healthcare plans to distribute to shareholders about 70%-80% of the $903 million it will get by selling its Gulf business, the hospital chain said Monday, days after a proxy advisory firm asked investors to veto the deal. Aster agreed, in November, to sell a majority stake in the Gulf business to private equity firm Fajr Capital in a $1 billion deal to help focus on its India business, which some investors considered undervalued. Last week, Institutional Investor Advisory Services asked Aster shareholders to vote against the deal due to a lack of clarity on how the company would use the sale proceeds, according to local media reports.
